Fecal and Serum Granulocyte Protein Levels in Inflammatory Bowel Disease and Irritable Bowel Syndrome and Their Relation to Disease Activity.

Helena Ekoff Niclas Rydell Per M Hellström Robert Movérare

Published in: Clinical and translational gastroenterology (2024)

Fecal MPO and serum NGAL are promising novel biomarkers, in addition to fecal CP, for differentiating between IBD and IBS. Serum NGAL may also predict disease activity in patients with UC.

Keyphrases

disease activity
systemic lupus erythematosus
rheumatoid arthritis
irritable bowel syndrome
rheumatoid arthritis patients
ankylosing spondylitis
juvenile idiopathic arthritis
peripheral blood
magnetic resonance imaging